<?xml version='1.0' encoding='UTF-8'?><device xmlns='http://www.fda.gov/cdrh/gudid' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance'><publicDeviceRecordKey>24a6a963-ba55-41f9-add1-ca5001ac4042</publicDeviceRecordKey><publicVersionStatus>Update</publicVersionStatus><deviceRecordStatus>Published</deviceRecordStatus><publicVersionNumber>3</publicVersionNumber><publicVersionDate>2026-04-20</publicVersionDate><devicePublishDate>2025-12-26</devicePublishDate><deviceCommDistributionEndDate xsi:nil="true"/><deviceCommDistributionStatus>In Commercial Distribution</deviceCommDistributionStatus><identifiers><identifier><deviceId>00613745003641</deviceId><deviceIdType>Primary</deviceIdType><deviceIdIssuingAgency>GS1</deviceIdIssuingAgency><containsDINumber xsi:nil="true"/><pkgQuantity xsi:nil="true"/><pkgDiscontinueDate xsi:nil="true"/><pkgStatus xsi:nil="true"/><pkgType xsi:nil="true"/></identifier></identifiers><brandName>NGSgo®-AmpX v2 HLA-DRB1 (96)</brandName><versionModelNumber>7370662</versionModelNumber><catalogNumber xsi:nil="true"/><dunsNumber>940425333</dunsNumber><companyName>GenBio</companyName><deviceCount>1</deviceCount><deviceDescription xsi:nil="true"/><DMExempt>false</DMExempt><premarketExempt>true</premarketExempt><deviceHCTP>false</deviceHCTP><deviceKit>true</deviceKit><deviceCombinationProduct>false</deviceCombinationProduct><singleUse>true</singleUse><lotBatch>true</lotBatch><serialNumber>false</serialNumber><manufacturingDate>false</manufacturingDate><expirationDate>true</expirationDate><donationIdNumber>false</donationIdNumber><labeledContainsNRL>false</labeledContainsNRL><labeledNoNRL>false</labeledNoNRL><MRISafetyStatus>Labeling does not contain MRI Safety Information</MRISafetyStatus><rx>false</rx><otc>false</otc><contacts><customerContact><phone>8585929300</phone><phoneExtension xsi:nil="true"/><email>orders@genbio.com</email></customerContact></contacts><gmdnTerms><gmdn><gmdnCode>56366</gmdnCode><gmdnPTName>HLA class II antigen nucleic acid tissue typing IVD, kit, nucleic acid technique (NAT)</gmdnPTName><gmdnPTDefinition>A collection of reagents and other associated materials intended to be used for the qualitative and/or quantitative detection of nucleic acid from one or multiple HLA class II antigens in a clinical specimen, using a nucleic acid technique (NAT). It may be used to detect specific HLA gene alleles associated with an inborn/inherited genetic disorder or a predisposition to develop an autoimmune disease (e.g., type 1 diabetes mellitus, Coeliac disease, narcolepsy, Crohn’s disease, inflammatory bowel disease (IBD), psoriasis and rheumatoid arthritis). It may also be used for selecting treatment options for immunotherapy.</gmdnPTDefinition><implantable>false</implantable><gmdnCodeStatus>Active</gmdnCodeStatus></gmdn></gmdnTerms><productCodes><fdaProductCode><productCode>MZI</productCode><productCodeName>Test, Qualitative, For Hla, Non-Diagnostic</productCodeName></fdaProductCode></productCodes><deviceSizes/><environmentalConditions/><sterilization><deviceSterile>false</deviceSterile><sterilizationPriorToUse>false</sterilizationPriorToUse><methodTypes/></sterilization></device>